The FDA is to review Sanofi/Regeneron's Dupixent as a treatment for asthma, a new use that could more than double its sales following its previous approval for eczema. Analysts predict peak annual ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were ...

The EMA has started a review of Leo Pharma’s interleukin-13 ... a category that is currently dominated by Sanofi and Regeneron’s Dupixent. The EU regulator is reviewing tralokinumab for ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...

The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.

In 2024, claim handling accounted for 65.2% of closed complaints. Here’s a deep look by claim, insurance and coverage type, and disposition. Consumers are increasingly filing insurance complaints as ...

In “The Age of Choice,” Sophia Rosenfeld questions whether choosing — what to buy, whom to vote for — is actually worth it. By Stephen Greenblatt In Anne Tyler’s new novel, a socially ...

In “Memorial Days,” Geraldine Brooks retreats to an island off Australia hoping to pick up the pieces after the sudden death of her husband. By Alexandra Jacobs In “The Age of Choice ...

This car is very good, its features are also very good, I like this car very much, please buy it, it ...

Wright made clear that his priorities are expanding production, streamlining regulations, and fostering innovation in the energy sector. Last week, Republicans and Democrats on the Senate ...

Kristin Koval’s novel explores the struggles of two families linked by tragedy, guilt and love. Two new books, “The Sirens’ Call” by Hayes and “Superbloom” by Carr, argue that our ...